| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/11/2026 | $60.00 | Buy | Citigroup |
| 2/5/2026 | $55.00 | Buy | Tigress Financial |
| 1/21/2026 | $50.00 → $55.00 | Buy | BTIG Research |
| 1/12/2026 | $48.00 | Buy | Citigroup |
| 1/12/2026 | $38.00 | Neutral | BNP Paribas Exane |
| 1/12/2026 | $50.00 | Overweight | Analyst |
| 1/12/2026 | $50.00 | Overweight | Piper Sandler |
| 1/12/2026 | $48.00 | Overweight | Morgan Stanley |
| 1/12/2026 | $47.00 | Outperform | RBC Capital Mkts |
| 1/12/2026 | $48.00 | Outperform | Mizuho |
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
Fastest customizable press release news feed in the world
NORTHFIELD, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that it plans to report first quarter 2026 financial results on Wednesday, May 6, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results. Information about Medline's financial results, including a link to the live webcast, will be available on the Events page of Medline's Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website. About MedlineMedline is the largest pr
Investment in combined robotic, conveyor and packing technology supports the delivery of medical supplies directly to homes of health plan members NORTHFIELD, Ill., April 6, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) has launched a fulfillment system called Pick Pack Pro™ at its distribution center in Montgomery, N.Y., marking a significant investment in advanced automation to support its health plan customers, including providers that administer Medicare benefits. Medline engineered Pick Pack Pro to help with orders that are pulled from a smaller range of products at high order volumes.
NORTHFIELD, Ill., April 3, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, announced this week its Golden Cone Awards to its top-performing manufacturing facilities in the U.S. These awards recognize Medline's seventeen manufacturing facilities in the United States across three size tiers based on employee count and hours worked, and are evaluated using monthly safety metrics, employee engagement in safety advocacy and awareness, and execution of an annual safety plan. Medline de
Awards selection is highest recognition for healthcare supply chain partnershipNORTHFIELD, Ill., April 1, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, announced today it was awarded two supply chain recognitions by the Healthcare Industry Resiliency Collaborative (HIRC), a neutral, nonprofit standardization organization that gives healthcare organizations tools to measure, compare and strengthen supply chain resiliency. Medline earned the HIRC Highest Member Choice Award for S
Groundbreaking is first operational initiative as a publicly traded company on its continued trajectory of growthNORTHFIELD, Ill., March 11, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) announced during a groundbreaking event this week that it plans to expand its national network of 45 distribution centers across the U.S. by constructing a new 1.2 million sq. ft. distribution center in Midlothian, Texas. The distribution center is to be fully operational in Q2 of 2027 and is the first new DC announced by Medline in 2026 and after its initial public offering in December of last year.
NORTHFIELD, Ill., March 10, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that it has closed its secondary offering of 86,250,000 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $41.00 per share, including the full exercise by the underwriters of their option to purchase up to an additional 11,250,000 shares of Medline's Class A common stock. Medline did not sell any shares of Class A common stock in the offering and did not
NORTHFIELD, Ill., March 9, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, announced this week its Distribution Center of the Year and Safety, Awareness for Everyone (SAFE) Award recipients to its top-performing facilities. These awards are given to the top-performing Medline distribution centers in the United States across its four tiers of size, as determined by the sales volume distributed out of each facility. Medline has been providing these awards to its highest-performing
NORTHFIELD, Ill., March 04, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today the pricing of a previously announced secondary offering of 75,000,000 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $41.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 11,250,000 shares of Medline's Class A common stock. The offering is expected to close on March 10, 2026, subj
NORTHFIELD, Ill., March 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") have commenced an underwritten public offering of 75,000,000 shares of Medline's Class A common stock pursuant to a registration statement filed with the Securities and Exchange Commission (the "SEC"). Additionally, the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 11,250,000 shares of Medline's Class A common stock. Med
Delivered strong full year 2025 resultsCompleted Initial Public OfferingIntroduced full year 2026 guidanceFourth quarter net sales of $7.8 billion, an increase of 14.8%Fourth quarter net income of $180 million, a decrease of 37.7%Fourth quarter Adjusted EBITDA1 of $805 million, approximately flatFull year net sales of $28.4 billion, an increase of 11.5%Full year net income of $1.2 billion, a decrease of 3.6%Full year Adjusted EBITDA1 of $3.5 billion, an increase of 3.2% NORTHFIELD, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline" or the "Company") (NASDAQ:MDLN), the largest provider of medical-surgical ("med-surg") products and supply chain solutions serving all points of c
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
4 - Medline Inc. (0002046386) (Issuer)
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Citigroup resumed coverage of Medline with a rating of Buy and set a new price target of $60.00
Tigress Financial initiated coverage of Medline with a rating of Buy and set a new price target of $55.00
BTIG Research reiterated coverage of Medline with a rating of Buy and set a new price target of $55.00 from $50.00 previously
Citigroup initiated coverage of Medline with a rating of Buy and set a new price target of $48.00
BNP Paribas Exane initiated coverage of Medline with a rating of Neutral and set a new price target of $38.00
Piper Sandler initiated coverage of Medline with a rating of Overweight and set a new price target of $50.00
Morgan Stanley initiated coverage of Medline with a rating of Overweight and set a new price target of $48.00
Analyst initiated coverage of Medline with a rating of Overweight and set a new price target of $50.00
RBC Capital Mkts initiated coverage of Medline with a rating of Outperform and set a new price target of $47.00
Mizuho initiated coverage of Medline with a rating of Outperform and set a new price target of $48.00
424B4 - Medline Inc. (0002046386) (Filer)
EFFECT - Medline Inc. (0002046386) (Filer)
S-1 - Medline Inc. (0002046386) (Filer)
S-8 - Medline Inc. (0002046386) (Filer)
10-K - Medline Inc. (0002046386) (Filer)
8-K - Medline Inc. (0002046386) (Filer)
SCHEDULE 13G - Medline Inc. (0002046386) (Subject)
SCHEDULE 13G - Medline Inc. (0002046386) (Subject)
SCHEDULE 13G - Medline Inc. (0002046386) (Subject)
SCHEDULE 13G - Medline Inc. (0002046386) (Subject)
Live finance-specific insights
NORTHFIELD, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that it plans to report first quarter 2026 financial results on Wednesday, May 6, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results. Information about Medline's financial results, including a link to the live webcast, will be available on the Events page of Medline's Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website. About MedlineMedline is the largest pr
NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results. Information about Medline's financial results, including a link to the live webcast, will be available on the Events page of Medline's Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website. About MedlineMedli